Related Experiment Video
Updated: Jun 1, 2026
12:09
Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Disease-related changes in TRPV1 expression and its implications for drug development
Louis S Premkumar1, Mahendra Bishnoi
1Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL 62702, USA. lpremkumar@siumed.edu
Current Topics in Medicinal Chemistry
|June 16, 2011
Summary
The transient receptor potential vanilloid 1 (TRPV1) channel, found in sensory neurons, is implicated in pain. Research explores its role in various diseases and its therapeutic potential for drug development.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- The transient receptor potential vanilloid 1 (TRPV1) channel is a key player in sensory neurobiology.
- Its expression extends beyond sensory neurons to non-neuronal cells, suggesting broader physiological roles.
- TRPV1's involvement in pain pathways has been extensively documented.
Purpose of the Study:
- To review disease-related alterations in TRPV1 expression and function.
- To explore the therapeutic potential of TRPV1 modulators (agonists and antagonists).
- To highlight TRPV1 as a drug development target for diverse diseases.
Main Methods:
- Literature review of studies on TRPV1 expression and function.
- Analysis of evidence linking TRPV1 to various pathological conditions.
- Synthesis of current research on TRPV1-targeted therapies.
Main Results:
- TRPV1 expression and function are altered in several disease states.
- Both TRPV1 agonists and antagonists show promise in preclinical studies.
- TRPV1's multifaceted roles support its consideration as a therapeutic target.
Conclusions:
- TRPV1 is a significant target for therapeutic intervention across a spectrum of diseases.
- Further research into TRPV1 modulation could lead to novel treatments.
- Understanding TRPV1's complex roles is crucial for drug development.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...